Roche Holding AG (LON:0QQ6)
London · Delayed Price · Currency is GBP · Price in CHF 278.10
+3.10 (1.13%)
At close: Jul 31, 2025
Roche Holding AG Company Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions.
The company was founded in 1896 and is based in Basel, Switzerland.
Roche Holding AG
| Country | Switzerland |
| Founded | 1896 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 103,249 |
| CEO | Thomas Schinecker |
Contact Details
Address: Grenzacherstrasse 124 Basel, 4070 Switzerland | |
| Phone | 41 61 688 88 80 |
| Website | roche.com |
Stock Details
| Ticker Symbol | 0QQ6 |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CHF |
| ISIN Number | CH0012032113 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Severin Schwan | Chief Executive Officer and Executive Director |
| Dr. Alan Hippe | Chief Financial Officer and Information Officer |
| Dr. Karl Mahler | Head of Investor Relations |
| Dr. Urs Jaisli | Chief Compliance Officer |
| Claudia Böckstiegel | General Counsel |
| Cristina A. Wilbur | Chief People Officer |
| Nicolas Dunant | Head of Group Media Relations |
| Ehab Yousef | Head of Middle East Sub-Region 1 |
| Boris L. Zaitra | Head of Group M&A |
| Lance Duan | Managing Director |